Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Shift to Fatty Substrate Utilization in Response to Sodium–Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes
Ferrannini, Ele, Baldi, Simona, Frascerra, Silvia, Astiarraga, Brenno, Heise, Tim, Bizzotto, Roberto, Mari, Andrea, Pieber, Thomas R., Muscelli, Elza
Published in Diabetes (New York, N.Y.) (01.05.2016)
Published in Diabetes (New York, N.Y.) (01.05.2016)
Get full text
Journal Article
Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes
Lambers Heerspink, H. J., de Zeeuw, D., Wie, L., Leslie, B., List, J.
Published in Diabetes, obesity & metabolism (01.09.2013)
Published in Diabetes, obesity & metabolism (01.09.2013)
Get full text
Journal Article
Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin
DeFronzo, Ralph A., Lewin, Andrew, Patel, Sanjay, Liu, Dacheng, Kaste, Renee, Woerle, Hans J., Broedl, Uli C.
Published in Diabetes care (01.03.2015)
Published in Diabetes care (01.03.2015)
Get full text
Journal Article
Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes
Lewin, Andrew, DeFronzo, Ralph A., Patel, Sanjay, Liu, Dacheng, Kaste, Renee, Woerle, Hans J., Broedl, Uli C.
Published in Diabetes care (01.03.2015)
Published in Diabetes care (01.03.2015)
Get full text
Journal Article
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease
Yale, J.-F., Bakris, G., Cariou, B., Yue, D., David-Neto, E., Xi, L., Figueroa, K., Wajs, E., Usiskin, K., Meininger, G.
Published in Diabetes, obesity & metabolism (01.05.2013)
Published in Diabetes, obesity & metabolism (01.05.2013)
Get full text
Journal Article
Dose-Ranging Effects of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-On to Metformin in Subjects With Type 2 Diabetes
Rosenstock, Julio, Aggarwal, Naresh, Polidori, David, Zhao, Yue, Arbit, Deborah, Usiskin, Keith, Capuano, George, Canovatchel, William
Published in Diabetes care (01.06.2012)
Published in Diabetes care (01.06.2012)
Get full text
Journal Article
Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Sodium Glucose Co‐Transporter 2 Inhibitor, in Subjects With Type 2 Diabetes Mellitus
Devineni, Damayanthi, Curtin, Christopher R., Polidori, David, Gutierrez, Maria J., Murphy, Joseph, Rusch, Sarah, Rothenberg, Paul L.
Published in Journal of clinical pharmacology (01.06.2013)
Published in Journal of clinical pharmacology (01.06.2013)
Get full text
Journal Article
Interaction Between the Sodium‐Glucose–Linked Transporter 2 Inhibitor Dapagliflozin and the Loop Diuretic Bumetanide in Normal Human Subjects
Wilcox, Christopher S., Shen, Wen, Boulton, David W., Leslie, Bruce R., Griffen, Steven C.
Published in Journal of the American Heart Association (20.02.2018)
Published in Journal of the American Heart Association (20.02.2018)
Get full text
Journal Article
Effect of Sodium‐Glucose Cotransport‐2 Inhibitors on Blood Pressure in People With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis of 43 Randomized Control Trials With 22 528 Patients
Mazidi, Mohsen, Rezaie, Peyman, Gao, Hong‐Kai, Kengne, Andre Pascal
Published in Journal of the American Heart Association (25.05.2017)
Published in Journal of the American Heart Association (25.05.2017)
Get full text
Journal Article
The Effects of Dapagliflozin on Systemic and Renal Vascular Function Display an Epigenetic Signature
Solini, Anna, Seghieri, Marta, Giannini, Livia, Biancalana, Edoardo, Parolini, Federico, Rossi, Chiara, Dardano, Angela, Taddei, Stefano, Ghiadoni, Lorenzo, Bruno, Rosa Maria
Published in The journal of clinical endocrinology and metabolism (01.10.2019)
Published in The journal of clinical endocrinology and metabolism (01.10.2019)
Get full text
Journal Article
The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58 Trial
Wiviott, Stephen D., Raz, Itamar, Bonaca, Marc P, Mosenzon, Ofri, Kato, Eri T, Cahn, Avivit, Silverman, Michael G, Bansilal, Sameer, Bhatt, Deepak L, Leiter, Lawrence A., McGuire, Darren K., Wilding, John PH, Gause-Nilsson, Ingrid AM, Langkilde, Anna Maria, Johansson, Peter A., Sabatine, Marc S.
Published in The American heart journal (01.06.2018)
Published in The American heart journal (01.06.2018)
Get full text
Journal Article
Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin
Devineni, D., Morrow, L., Hompesch, M., Skee, D., Vandebosch, A., Murphy, J., Ways, K., Schwartz, S.
Published in Diabetes, obesity & metabolism (01.06.2012)
Published in Diabetes, obesity & metabolism (01.06.2012)
Get full text
Journal Article
First-in-human study to assess the safety, tolerability, and pharmacokinetics of intravenous SHPL-49 following single- and multiple-ascending-dose administration in healthy adults
Li, Shuya, Yang, Cuicui, Wang, Weicong, Li, Jian, Xu, Shuhong, Zhao, Min, Xu, Chunmin, Wang, Jiaqing, Wang, Yongjun
Published in Journal of pharmaceutical and biomedical analysis (15.10.2024)
Published in Journal of pharmaceutical and biomedical analysis (15.10.2024)
Get full text
Journal Article
Pharmacokinetics, pharmacodynamics and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in subjects with renal impairment
Macha, S., Mattheus, M., Halabi, A., Pinnetti, S., Woerle, H. J., Broedl, U. C.
Published in Diabetes, obesity & metabolism (01.03.2014)
Published in Diabetes, obesity & metabolism (01.03.2014)
Get full text
Journal Article
Determinants of the increase in ketone concentration during SGLT2 inhibition in NGT, IFG and T2DM patients
Al Jobori, Hussein, Daniele, Giuseppe, Adams, John, Cersosimo, Eugenio, Triplitt, Curtis, DeFronzo, Ralph A., Abdul‐Ghani, Muhammad
Published in Diabetes, obesity & metabolism (01.06.2017)
Published in Diabetes, obesity & metabolism (01.06.2017)
Get full text
Journal Article
Pharmacokinetics and pharmacodynamics of empagliflozin in paediatric patients aged 10–17 years with type 2 diabetes mellitus
Rascher, Juliane, Cheng, Shen, Johnston, Curtis, Härtter, Sebastian, Jan‐Georg, Wojtyniak, Marquard, Jan, Tartakovsky, Igor, Laffel, Lori M. B.
Published in British journal of clinical pharmacology (01.08.2025)
Published in British journal of clinical pharmacology (01.08.2025)
Get full text
Journal Article
Impact of sodium-glucose cotransporter inhibitors in acute coronary syndrome patients on endothelial function and atherosclerosis related-biomarkers: ATH-SGLT2i pilot study
Mghaieth Zghal, Fathia, Abbassi, Manel, Silini, Ahlem, Ben Halima, Manel, Jebberi, Zeynab, Daly, Foued, Ouali, Sana, Farhati, Abdeljelil, Ben Mansour, Nadia, Boudiche, Selim, Mourali, Mohamed Sami
Published in Medicine (Baltimore) (22.11.2024)
Published in Medicine (Baltimore) (22.11.2024)
Get full text
Journal Article